Edit
Faculty: Rebecca Laposa, PhD
https://www.pharmtox.utoronto.ca/faculty-rebecca-laposa-phdLast activity: -
Development of novel small-molecule inhibitors that target cancer cell mitochondria, a fuel source that many cancer cells rely on during chemotherapy. The initial indication for this potential drug candidate is high-risk early breast cancer.